Search Result Products - CapitalBio Technology Co., Ltd.

All Related Products Other Content

The Disease Susceptibility Genetic Test-Breast Cancer The test is based on biochip technology，evaluates the risk of breast cancer from the perspective of genetics and provide guidance on disease prevention.
Hybridization Box CapitalBio HybSetTM Microarray Hybridization Box holds a 25mm 75mm microarray slide to prevent solution evaporation.
Mycobacteria Species Identification The rapid identification of 17 clinically important mycobacterial species enables precise targeting of pathogenic strain types.
Drug-Related Deafnss Gene Mutations Detection The Drug-Related Deafness Gene Mutations Detection service focuses on detecting drug-induced deafness genes.
Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic] This test detects somatic and germline mutations in the BRCA1 and BRCA2 genes, provide information to guide PARP inhibitor therapy in breast & ovarian cancer.
The Disease Susceptibility Genetic Test-Colorectal Cancer The test is based on biochip technology, evaluates the risk of colorectal cancer from the perspective of genetics and provide guidance on disease prevention.
MTB Drug Resistant Detection MDR-TB disease can be quickly diagnosed by using gene chip technology to quickly test for resistance to rifampicin and isoniazid, two of the most important first-line anti-TB drugs.
100 Loci of 18 Deafness-Related Genes Detection Using next-generation sequencing technology, it can test 100 loci in 18 deafness-related genes in humans to determine if there are mutation sites in the deafness gene.
Individualized Medication Guidance for Breast Cancer This test detects 348 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.
The Disease Susceptibility Genetic Test-Esophageal Cancer This test bases on biochip technology evaluates the risk of esophageal cancer from the perspective of genetics and provide guidance on disease prevention.
Human Papillomavirus (HPV) Genotyping Detection HPV is divided into two types based on the risk of carcinogenicity: high-risk and low-risk. Persistent infection with high-risk HPV is a clear cause of cervical cancer.
Hereditary Deafness Gene Detection (227 Genes+Mitochondrial Genome) Using next-generation sequencing technology, 227 deafness-related genes and the entire mitochondrial genome sequence are identified to provide precise guidance for molecular disease diagnosis.
Individualized Medication Guidance for Gynecologic Cancer This test detects 348 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for gynecologic cancer patients.
The Disease Susceptibility Genetic Test-High Incidence Cancer (6 Items) This test bases on biochip technology, evaluates the risk of high-incidence cancers from the perspective of genetics, and provide guidance to disease prevention.
Breast Cancer Prognosis Assessment This test can aid in the development of breast cancer treatment plans and avoid conditions such as undertreatment or overtreatment.

«
1
2
3
4
5
6
... 7
»